A detailed history of California State Teachers Retirement System transactions in Annexon, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 6,994 shares of ANNX stock, worth $36,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,994
Previous 6,104 14.58%
Holding current value
$36,578
Previous $29,000 41.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $3,996 - $6,408
890 Added 14.58%
6,994 $41,000
Q2 2024

Aug 14, 2024

SELL
$4.33 - $6.79 $2,901 - $4,549
-670 Reduced 9.89%
6,104 $29,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $2,974 - $5,763
-738 Reduced 9.82%
6,774 $48,000
Q4 2023

Feb 13, 2024

SELL
$1.63 - $4.63 $4,171 - $11,848
-2,559 Reduced 25.41%
7,512 $34,000
Q3 2023

Nov 14, 2023

SELL
$2.13 - $3.84 $10,888 - $19,630
-5,112 Reduced 33.67%
10,071 $23,000
Q2 2023

Aug 21, 2023

BUY
$2.1 - $6.37 $31,884 - $96,715
15,183 New
15,183 $53,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $69,397 - $133,533
-32,890 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $9,219 - $40,321
-3,377 Reduced 9.31%
32,890 $90,000
Q4 2021

Feb 15, 2022

BUY
$11.49 - $22.0 $79,143 - $151,536
6,888 Added 23.45%
36,267 $417,000
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $222,687 - $318,708
-13,620 Reduced 31.68%
29,379 $547,000
Q2 2021

Aug 16, 2021

BUY
$17.81 - $27.48 $49,387 - $76,202
2,773 Added 6.89%
42,999 $968,000
Q1 2021

May 18, 2021

BUY
$22.0 - $35.01 $365,266 - $581,271
16,603 Added 70.28%
40,226 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$20.81 - $30.55 $27,323 - $40,112
1,313 Added 5.89%
23,623 $591,000
Q3 2020

Nov 17, 2020

BUY
$17.5 - $30.23 $390,425 - $674,431
22,310 New
22,310 $674,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.